Similar to our data, SAMHD1 effect on antineoplastic drug efficacy was first demonstrated in vivo with cytarabine, the standard treatment for AML, where SAMHD1 expression results in limited cytarabine efficacy due to enhanced hydrolysis of the active metabolite [19,20]. Here, SAMHD1 is linked to acute myeloid leukemia.